Schizophrenia: From genes to phenes to disease

Current Psychiatry Reports

Volumn 10, Issue 4, 2008, Pages 339-343

  Allan, Charlotte L ^a   Cardno, Alastair G ^b   McGuffin, Peter ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CATECHOL METHYLTRANSFERASE; DEXTRO AMINO ACID OXIDASE ACTIVATOR; DISRUPTED IN SCHIZOPHRENIA 1; DOPAMINE; DYSBINDIN; GENE PRODUCT; NEU DIFFERENTIATION FACTOR;

BIPOLAR DISORDER; CLINICAL PRACTICE; DISEASE CLASSIFICATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENOTYPE; HUMAN; MOLECULAR GENETICS; NEUROIMAGING; NONHUMAN; PHENOTYPE; PSYCHOSIS; QUANTITATIVE GENETICS; REVIEW; SCHIZOPHRENIA;

CATECHOL O-METHYLTRANSFERASE; CHROMOSOME ABERRATIONS; DOPAMINE; GENE EXPRESSION; GENOTYPE; HUMANS; LINKAGE (GENETICS); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NERVE TISSUE PROTEINS; PHENOTYPE; SCHIZOPHRENIA; TWINS;

EID: 48749128244     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0054-x     Document Type: Review

References (49)

1. Craddock N, O'Donovan MC, Owen MJ: The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005, 42:193-204.
2. Lichtenstein P, Björk C, Hultman CM: Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med 2006, 36:1417-1425.
3. Craddock N, O'Donovan MC, Owen MJ: Phenotypic and genetic complexity of psychosis. Invited commentary on schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 2007, 190:200-203.
4. Braff D, Schork NJ, Gottesman II: Endophenotyping schizophrenia. Am J Psychiatry 2007, 164:705-707.
5. Greenwood TA, Braff DL, Light GA, et al.: Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007, 64:1242-1250.
6. Bearden CE, van Erp TG, Thompson PM: Cortical mapping of genotype-phenotype relationships in schizophrenia. Hum Brain Mapp 2007, 28:519-532.
7. Cannon TD, Keller MC: Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol 2006, 2:267-290.
8. Burdick KE, Goldberg TE, Funke B, et al.: DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res 2007, 89:169-172.
9. Hall MH, Rijsdijk F, Picchioni M, et al.: Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry 2007, 164:804-812.
10. Toulopoulou T, Picchioni M, Rijsdijk F, et al.: Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch Gen Psychiatry 2007, 64:1348-1355.
11. Karlsgodt KH, Glahn DC, van Erp TG, et al.: The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res 2007, 89:191-197.
12. McClellan JM, Susser E, King MC: Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 2007, 190:194-199.
13. Crow TJ: How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 2007, 164:13-21.
14. Faraone SV, Hwu HG, Liu CM, et al.: Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. Am J Psychiatry 2006, 163:1760-1766.
15. Bulayeva KB, Glatt SJ, Bulayev OA, et al.: Genome-wide linkage scan of schizophrenia: a cross-isolate study. Genomics 2007, 89:167-177.
16. Fanous AH, Neale MC, Webb BT, et al.: A genome-wide scan for modifier loci in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2007, 144:589-595.
17. The Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
18. Owen MJ, Craddock N, Jablensky A: The genetic deconstruction of psychosis. Schizophr Bull 2007, 33:905-911.
19. Li D, He L: Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res 2007, 96:112-118.
20. Bray NJ, Holmans PA, van den Bree MB, et al.: Cis- and trans-loci influence expression of the schizophrenia susceptibility gene DTNBP1. Hum Mot Genet 2008, 17:1169-1174.
21. DeRosse P, Funke B, Burdick KE, et al.: Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 2006, 163:532-534.
22. Fanous AH, van den Oord EJ, Riley BP, et al.: Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 2005, 162:1824-1832.
23. Harrison PJ, Law AJ: Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006, 60:132-140.
24. Muna fò MR, Attwood AS, Flint J: Neuregulin 1 genotype and schizophrenia. Schizophr Bull 2008, 34:9-12.
25. Turunen JA: The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res 2007, 91:27-36.
26. Thomson PA, Christoforou A, Morris SW, et al.: Association of neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 2007, 12:94-104.
27. Malhi GS, Lagopoulos J: Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand 2008, 117:100-117.
28. Konrad A, Winterer G: Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull 2008, 34:72-92.
29. O'Tuathaigh CM, Babovic D, O'Meara G, et al.: Suceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. Neurosci Biobehav Rev 2007, 31:60-78.
30. Chubb JE, Bradshaw NJ, Soares DC, et al.: The DISC locus in psychiatric illness. Mol Psychiatry 2008, 13:36-64.
31. Matsuzaki S, Tohyama M: Molecular mechanism of schizophrenia with reference to disrupted-in -schizophrenia 1 (DISC 1). Neurochem Int 2007, 51:165-172.
32. Mackie S, Millar JK, Porteous DJ: Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol 2007, 17:95-102.
33. Sanders AR, Duan J, Levinson DF, et al.: No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
34. Roberts RC: Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr Bull 2007, 33:11-15.
35. Garety PA, Bebbington P, Fowler D, et al.: Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychol Med 2007, 37:1377-1391.
36. Chumakov I, Blumenfeld M, Guerassimenko O, et al.: Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002, 99:13675-13680.
37. Corvin A, McGhee KA, Murphy K, et al.: Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet 2007, 144:949-953.
38. Wood LS, Pickering EH, Dechairo BM: Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry 2007, 61:1195-1199.
39. Spurlock G, Williams J, McGuffin P, et al.: European multicentre association study of schizophrenia: a study of the DRD2 Ser311 Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 1998, 81:24-28.
40. Talkowski ME, Bamne M, Mansour H, et al.: Dopamine genes and schizophrenia: case closed or evidence pending? Schizophr Bull 2007, 33:1071-1081.
41. Yu R, Zhang XN, Huang XX, et al.: Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study. Am J Med Genet B Neuropsychiatr Genet 2007, 144:570-573.
42. Gothelf D, Feinstein C, Thompson T, et al.: Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 2007, 164:663-669.
43. Williams HJ, Owen MJ, O'Donovan MC: Is COMT a susceptibility gene for schizophrenia? Schizophr Bull 2007, 33:635-641.
44. Ma X, Sun J, Yao J, et al.: A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population. Psychiatry Res 2007, 153:7-15.
45. Zinkstok J, Schmitz N, van Amelsvoort T, et al.: Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes Brain Behav 2008, 7:61-69.
46. Gilbody S, Lewis S, Lightfoot T: Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorder: a HuGE review. Am J Epidemiol 2007, 165:1-13.
47. Gaysina D, Cohen S, Craddock N, et al.: No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2007 Dec 28 (Epub ahead of print).
48. Farmer A, Elkin A, McGuffin P: The genetics of bipolar affective disorder. Curr Opin Psychiatry 2007, 20:8-12.
49. Lake CR, Hurwitz N: Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - there is no schizoaffective disorder. Curr Opin Psychiatry 2007, 20:365-379.